<DOC>
	<DOCNO>NCT01260870</DOCNO>
	<brief_summary>To evaluate procedural safety identify characterize therapeutic functional endpoint assessment subject document critical limb ischemia receive treatment Cotavance Paclitaxel-Coated Balloon vs. receive POBA .</brief_summary>
	<brief_title>European Study POBA Versus Cotavance ( R ) Paclitaxel Coated Balloon Treatment Infrapopliteal Lesions Critical Limb Ischemia ( EURO CANAL )</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>Subjects CLI Participation another research trial Medical condition study doctor ass</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>